20
Alp Pharm Beijing Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is CLEVIDIPINE BUTYRATE, with a corresponding US DMF Number 29850.
Remarkably, this DMF maintains an Active status since its submission on August 10, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 25, 2019, and payment made on May 25, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II